Psychedelics: New Frontiers in Alternative Medicine

The Path to Legalized, Accessible Psilocybin Therapy

June 08, 2022

Feature

What would legalization and widespread availability of psilocybin therapy look like? Here, we connect with Dr. Sunil Aggarwal, a palliative care physician and cofounder of the Advanced Integrative Medical Science Institute (AIMS) in Seattle, Washington, to find out.

A New Clinical Trial in South Africa Aims to Study the Effect of Psilocybin on HIV Positive Women with Major Depressive Disorder

June 08, 2022

Feature

In this interview, Donaghue Woodman, Head of Research and Development and Chief Medical Information Officer at Cannsun, provides an in-depth look at their current clinical trial on the effects of psilocybin in treating a prevalent yet unresolved issue in South Africa.

Psilocybin Therapy for PTSD and Depression

June 08, 2022

Feature

An overview of the therapeutic role of psychedelics that goes back thousands of years, as well as the new research and the application of microdosing principles that have created renewed interest in the power of psychedelics.

Cannabis and Psychedelics Research: A Cannabis Science Conference West Preview with Dr. Denise Vidot

March 31, 2022

Feature

Dr. Denise C. Vidot, an epidemiologist at the University of Miami and Founder of the International Cannabis & Psychedelic Research Collaborative, shares her research background, a small preview of her talk, “Co-Use of Cannabis and Psilocybin to Manage Mental Health Amid the COVID-19 Pandemic: Preliminary Results from the International COVID-19 Cannabis Health Study,” and more.